Physician

Jorge Alberto Jimenez, M.D.

According to 2025 Medicare claims, Jorge Jimenez, M.D. (NPI: 1518353168) practices ophthalmology in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is SOUTH CAROLINA RETINA INSTITUTE LLC (NPI: 1417581638; TIN: 843234305) and primary practice location at 29572-9998.

Jimenez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 815 traditional Medicare patients, billed 77,362 HCPCS/CPT codes, and received $2,792,658 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,077 prescription claims across 286 beneficiaries totaling $35,081 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 27 records totaling $583. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $7,100 to $2,792,658. Similarly, Part D prescription costs have risen steadily, from $3,942 to $35,081. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.8M2019 Medicare payment: $7,100 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $6,443 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $137,931 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $701,445 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $802,008 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,792,658 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20195694$7,100
20204057$6,443
2021192879$137,931
20223344,170$701,445
20235278,122$802,008
202481577,362$2,792,658

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$18K$35K2015 Drug cost: $3,942 (USD; Tot_Drug_Cst)2016 Drug cost: $6,318 (USD; Tot_Drug_Cst)2017 Drug cost: $3,286 (USD; Tot_Drug_Cst)2018 Drug cost: $3,737 (USD; Tot_Drug_Cst)2019 Drug cost: $12,627 (USD; Tot_Drug_Cst)2020 Drug cost: $11,206 (USD; Tot_Drug_Cst)2021 Drug cost: $12,866 (USD; Tot_Drug_Cst)2022 Drug cost: $16,386 (USD; Tot_Drug_Cst)2023 Drug cost: $26,707 (USD; Tot_Drug_Cst)2024 Drug cost: $35,081 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151132$3,942
20162967$6,318
201754129$3,286
201850108$3,737
201999255$12,627
2020115321$11,206
2021100251$12,866
2022128461$16,386
2023178598$26,707
20242861,077$35,081

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more491491$116
67028Injection of drug into eye3041,351$90
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more482877$89
92134Imaging of retina7492,228$29
92250Photography of the retina332464$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate37412,281$18,240
DifluprednateDifluprednate37742$3,614
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat15611,071$2,417
Brimonidine TartrateBrimonidine Tartrate884,620$1,170
OfloxacinOfloxacin852,031$975

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.27$583Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jorge Alberto Jimenez, M.D.?

Tedicare shows public-source Medicare data for Jorge Alberto Jimenez, M.D. (NPI 1518353168), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jorge Alberto Jimenez, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jorge Alberto Jimenez, M.D.?

Jorge Alberto Jimenez, M.D. is linked to SOUTH CAROLINA RETINA INSTITUTE LLC (billing NPI 1417581638) in the available physician profile data.

Does Jorge Alberto Jimenez, M.D. have Open Payments data?

Jorge Alberto Jimenez, M.D. has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.